Acacia Research (ACTG) Cash & Equivalents (2010 - 2026)

Acacia Research's Cash & Equivalents history runs 17 years deep, the most recent figure standing at $307.5 million for Q1 2026.

• In Q1 2026, Cash & Equivalents rose 13.07% year-over-year to $307.5 million; the TTM figure through Mar 2026 stood at $307.5 million (up 13.07% YoY), while the FY2025 annual figure was $306.7 million, up 11.99% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $307.5 million, roughly flat from $306.7 million in the prior quarter.
• The five-year high for Cash & Equivalents was $438.8 million in Q1 2024, with the low at $241.9 million in Q3 2022.
• The 5-year median for Cash & Equivalents is $307.5 million (2026), against an average of $320.7 million.
• The sharpest annual moves came in 2022 and 2025: Cash & Equivalents jumped 99.83% in 2022, then tumbled 38.02% in 2025.
• Acacia Research's Cash & Equivalents stood at $287.8 million in 2022, then gained by 18.17% to $340.1 million in 2023, then retreated by 19.47% to $273.9 million in 2024, then rose by 11.99% to $306.7 million in 2025, then climbed by 0.26% to $307.5 million in 2026.
• Business Quant data shows ACTG's Cash & Equivalents at $307.5 million in Q1 2026, $306.7 million in Q4 2025, and $301.8 million in Q3 2025.